One of the goals of the recently developed ICC and proposed 5th edition of the WHO classification of acute leukemias was to move to a genetically defined classification, and thus, both classifications now recognize MDS‐associated mutations as defining myelodysplasia‐related AML, with only difference being inclusion of RUNX1 in ICC. This evidence concerns the gene RUNX1 and acute myeloid leukemia.